Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$236K Sell
853
-1
-0.1% -$256 0.36% 52
2026
Q2
$215K Sell
854
-392
-31% -$84.3K 0.31% 60
2026
Q1
$271K Buy
1,246
+1
+0.1% +$222 0.32% 68
2025
Q4
$284K Hold
1,245
– – 0.34% 57

Other funds holding ABBV

Altar Rock's ABBV Position: Q3 2026 in Review

Altar Rock reduced its AbbVie (ABBV) stake by 0.12% in Q3 2026, selling an estimated $256 and leaving 853 shares worth $236K. The position accounts for 0.36% of the portfolio, ranked #52.

Altar Rock first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $284K in Q4 2025. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Altar Rock held 853 shares of AbbVie worth $236K as of Q3 2026.
  • Altar Rock sold 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.36% of Altar Rock's portfolio in Q3 2026, its #52 holding.
  • Altar Rock first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Altar Rock's AbbVie position peaked at $284K in Q4 2025.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Altar Rock's 13F filing for Q3 2026, filed 6 Nov 2026.